AKT1 and urinary bladder neoplasm: Bladder tumors are highly heterogeneous, with frequent mutations in different signaling pathways, including cell cycle genes, receptors’ tyrosine kinase, PI3K/AKT/mTOR, and chromatin regulatory gene mutations [16].